Search or
𝛼SK
𝛼SKbullish
Exencial Industry Tidings 09/09/2025
198 Views09 Sep 2025 16:14
Crisil predicts 6-7% revenue growth for India Inc due to GST cuts, Britannia aims for 50% domestic sales from rural markets, Mankind gets approval for autoimmune molecule trials.
What is covered in the Full Insight:
- India-Israel Bilateral Investment Treaty
- GST Impact and Economic Growth
- SCM Trade Concerns
- GST Revenue Expectations
- Export Controls and Market Access
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 28-minute read)
Discussions
(Paid Plans Only)
- Loading...
x